Der leads study published in Science Signaling

August 13, 2019

UNC Lineberger’s Channing Der, PhD, Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, was corresponding author of a paper published in Science Signaling. The study identified a potential therapeutic target for patients with KRAS-mutant pancreatic ductal adenocarcinoma. Der and his colleagues described in the paper the use of a screening strategy … Continued